In recent years, different Convolutional Neural Networks (CNNs) approaches have been applied for image classification in general and specific problems such as breast cancer diagnosis, but there is no standardising approach to facilitate comparison and synergy. This paper attempts a step-by-step approach to standardise a common application of image classification with the specific problem of classifying breast ultrasound images for breast cancer diagnosis as an illustrative example. In this study, three distinct datasets: Breast Ultrasound Image (BUSI), Breast Ultrasound Image (BUI), and Ultrasound Breast Images for Breast Cancer (UBIBC) datasets have been used to build and fine-tune custom and pre-trained CNN models systematically. Custom CNN models have been built, and hence, transfer learning (TL) has been applied to deploy a broad range of pre-trained models, optimised by applying data augmentation techniques and hyperparameter tuning. Models were trained and tested in scenarios involving limited and large datasets to gain insights into their robustness and generality. The obtained results indicated that the custom CNN and VGG19 are the two most suitable architectures for this problem. The experimental results highlight the significance of employing an effective step-by-step approach in image classification tasks to enhance the robustness and generalisation capabilities of CNN-based classifiers.

The scarcity and imbalance of medical image datasets hinder the development of robust computer-aided diagnosis (CAD) systems for breast cancer. This study explores the application of advanced generative models, based on generative artificial intelligence (GenAI), for the synthesis of digital breast ultrasound images. Using a hybrid Conditional Variational Autoencoder-Wasserstein Generative Adversarial Network (CVAE-WGAN) architecture, we developed a system to generate high-quality synthetic images conditioned on the class (malignant vs. normal/benign). These synthetic images, generated from the low-resolution BreastMNIST dataset and filtered for quality, were systematically integrated with real training data at different mixing ratios (W). The performance of a CNN classifier trained on these mixed datasets was evaluated against a baseline model trained only on real data balanced with SMOTE. The optimal integration (mixing weight W=0.25) produced a significant performance increase on the real test set: +8.17% in macro-average F1-score and +4.58% in accuracy compared to using real data alone. Analysis confirmed the originality of the generated samples. This approach offers a promising solution for overcoming data limitations in image-based breast cancer diagnostics, potentially improving the capabilities of CAD systems.

BackgroundDelays in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) contribute to the significant morbidity of the condition, especially in the era of disease-modifying therapies. Screening for ATTR-CM with AI and other algorithms may improve timely diagnosis, but these algorithms have not been directly compared. ObjectivesThe aim of this study was to compare the performance of four algorithms for ATTR-CM detection in a heart failure population and assess the risk for harms due to model bias. MethodsWe identified patients in an integrated health system from 2010-2022 with ATTR-CM and age- and sex-matched them to controls with heart failure to target 5% prevalence. We compared the performance of a claims-based random forest model (Huda et al. model), a regression-based score (Mayo ATTR-CM), and two deep learning echo models (EchoNet-LVH and EchoGo(R) Amyloidosis). We evaluated for bias using standard fairness metrics. ResultsThe analytical cohort included 176 confirmed cases of ATTR-CM and 3192 control patients with 79.2% self-identified as White and 9.0% as Black. The Huda et al. model performed poorly (AUC 0.49). Both deep learning echo models had a higher AUC when compared to the Mayo ATTR-CM Score (EchoNet-LVH 0.88; EchoGo Amyloidosis 0.92; Mayo ATTR-CM Score 0.79; DeLong P<0.001 for both). Bias auditing met fairness criteria for equal opportunity among patients who identified as Black. ConclusionsDeep learning, echo-based models to detect ATTR-CM demonstrated best overall discrimination when compared to two other models in external validation with low risk of harms due to racial bias.

BackgroundAcute appendicitis remains a challenging diagnosis in pediatric populations, with high rates of misdiagnosis and negative appendectomies despite advances in imaging modalities. Current diagnostic tools, including clinical scoring systems like Alvarado and Pediatric Appendicitis Score (PAS), lack sufficient sensitivity and specificity, while reliance on CT scans raises concerns about radiation exposure, contrast hazards and sedation in children. Moreover, no established tool effectively predicts progression from uncomplicated to complicated appendicitis, creating a critical gap in clinical decision-making. ObjectiveTo develop and evaluate a machine learning model that integrates clinical, laboratory, and radiological findings for accurate diagnosis and complication prediction in pediatric appendicitis and to deploy this model as an interpretable web-based tool for clinical decision support. MethodsWe analyzed data from 780 pediatric patients (ages 0-18) with suspected appendicitis admitted to Childrens Hospital St. Hedwig, Regensburg, between 2016 and 2021. For severity prediction, our dataset was augmented with 430 additional cases from published literature and only the confirmed cases of acute appendicitis(n=602) were used. After feature selection using statistical methods and recursive feature elimination, we developed a Random Forest model named Dharma, optimized through hyperparameter tuning and cross-validation. Model performance was evaluated on independent test sets and compared with conventional diagnostic tools. ResultsDharma demonstrated superior diagnostic performance with an AUC-ROC of 0.96 ({+/-}0.02 SD) in cross-validation and 0.97-0.98 on independent test sets. At an optimal threshold of 64%, the model achieved specificity of 88%-98%, sensitivity of 89%-95%, and positive predictive value of 93%-99%. For complication prediction, Dharma attained a sensitivity of 93% ({+/-}0.05 SD) in cross-validation and 96% on the test set, with a negative predictive value of 98%. The model maintained strong performance even in cases where the appendix could not be visualized on ultrasonography (AUC-ROC 0.95, sensitivity 89%, specificity 87% at the threshold of 30%). ConclusionDharma is a novel, interpretable machine learning based clinical decision support tool designed to address the diagnostic challenges of pediatric appendicitis by integrating easily obtainable clinical, laboratory, and radiological data into a unified, real-time predictive framework. Unlike traditional scoring systems and imaging modalities, which may lack specificity or raise safety concerns in children, Dharma demonstrates high accuracy in diagnosing appendicitis and predicting progression from uncomplicated to complicated cases, potentially reducing unnecessary surgeries and CT scans. Its robust performance, even with incomplete imaging data, underscores its utility in resource-limited settings. Delivered through an intuitive, transparent, and interpretable web application, Dharma supports frontline providers--particularly in low- and middle-income settings--in making timely, evidence-based decisions, streamlining patient referrals, and improving clinical outcomes. By bridging critical gaps in current diagnostic and prognostic tools, Dharma offers a practical and accessible 21st-century solution tailored to real-world pediatric surgical care across diverse healthcare contexts. Furthermore, the underlying framework and concepts of Dharma may be adaptable to other clinical challenges beyond pediatric appendicitis, providing a foundation for broader applications of machine learning in healthcare. Author SummaryAccurate diagnosis of pediatric appendicitis remains challenging, with current clinical scores and imaging tests limited by sensitivity, specificity, predictive values, and safety concerns. We developed Dharma, an interpretable machine learning model that integrates clinical, laboratory, and radiological data to assist in diagnosing appendicitis and predicting its severity in children. Evaluated on a large dataset supplemented by published cases, Dharma demonstrated strong diagnostic and prognostic performance, including in cases with incomplete imaging--making it potentially especially useful in resource-limited settings for early decision-making and streamlined referrals. Available as a web-based tool, it provides real-time support to healthcare providers in making evidence-based decisions that could reduce negative appendectomies while avoiding hazards associated with advanced imaging modalities such as sedation, contrast, or radiation exposure. Furthermore, the open-access concepts and framework underlying Dharma have the potential to address diverse healthcare challenges beyond pediatric appendicitis.

BackgroundThis study aims to present the Segmentation-based Myocardial Advanced Refinement Tracking (SMART) system, a novel artificial intelligence (AI)-based framework for transthoracic echocardiography (TTE) that incorporates motion tracking and left ventricular (LV) myocardial segmentation for automated LV mass (LVM) and global longitudinal strain (LVGLS) assessment. MethodsThe SMART system demonstrates LV speckle tracking based on motion vector estimation, refined by structural information using endocardial and epicardial segmentation throughout the cardiac cycle. This approach enables automated measurement of LVMSMART and LVGLSSMART. The feasibility of SMART is validated in 111 hypertrophic cardiomyopathy (HCM) patients (median age: 58 years, 69% male) who underwent TTE and cardiac magnetic resonance imaging (CMR). ResultsLVGLSSMART showed a strong correlation with conventional manual LVGLS measurements (Pearsons correlation coefficient [PCC] 0.851; mean difference 0 [-2-0]). When compared to CMR as the reference standard for LVM, the conventional dimension-based TTE method overestimated LVM (PCC 0.652; mean difference: 106 [90-123]), whereas LVMSMART demonstrated excellent agreement with CMR (PCC 0.843; mean difference: 1 [-11-13]). For predicting extensive myocardial fibrosis, LVGLSSMART and LVMSMART exhibited performance comparable to conventional LVGLS and CMR (AUC: 0.72 and 0.66, respectively). Patients identified as high-risk for extensive fibrosis by LVGLSSMART and LVMSMART had significantly higher rates of adverse outcomes, including heart failure hospitalization, new-onset atrial fibrillation, and defibrillator implantation. ConclusionsThe SMART technique provides a comparable LVGLS evaluation and a more accurate LVM assessment than conventional TTE, with predictive values for myocardial fibrosis and adverse outcomes. These findings support its utility in HCM management.

AimsAortic stenosis (AS) is a progressive disease requiring timely monitoring and intervention. While transthoracic echocardiography (TTE) remains the diagnostic standard, deep learning (DL)-based approaches offer potential for improved disease tracking. This study examined the longitudinal changes in a previously developed DL-derived index for AS continuum (DLi-ASc) and assessed its value in predicting progression to severe AS. Methods and ResultsWe retrospectively analysed 2,373 patients a(7,371 TTEs) from two tertiary hospitals. DLi-ASc (scaled 0-100), derived from parasternal long- and/or short-axis views, was tracked longitudinally. DLi-ASc increased in parallel with worsening AS stages (p for trend <0.001) and showed strong correlations with AV maximal velocity (Vmax) (Pearson correlation coefficients [PCC] = 0.69, p<0.001) and mean pressure gradient (mPG) (PCC = 0.66, p<0.001). Higher baseline DLi-ASc was associated with a faster AS progression rate (p for trend <0.001). Additionally, the annualised change in DLi-ASc, estimated using linear mixed-effect models, correlated strongly with the annualised progression of AV Vmax (PCC = 0.71, p<0.001) and mPG (PCC = 0.68, p<0.001). In Fine-Gray competing risk models, baseline DLi-ASc independently predicted progression to severe AS, even after adjustment for AV Vmax or mPG (hazard ratio per 10-point increase = 2.38 and 2.80, respectively) ConclusionDLi-ASc increased in parallel with AS progression and independently predicted severe AS progression. These findings support its role as a non-invasive imaging-based digital marker for longitudinal AS monitoring and risk stratification.

The Segment Anything Model (SAM) was fine-tuned on the EchoNet-Dynamic dataset and evaluated on external transthoracic echocardiography (TTE) and Point-of-Care Ultrasound (POCUS) datasets from CAMUS (University Hospital of St Etienne) and Mayo Clinic (99 patients: 58 TTE, 41 POCUS). Fine-tuned SAM was superior or comparable to MedSAM. The fine-tuned SAM also outperformed EchoNet and U-Net models, demonstrating strong generalization, especially on apical 2-chamber (A2C) images (fine-tuned SAM vs. EchoNet: CAMUS-A2C: DSC 0.891 {+/-} 0.040 vs. 0.752 {+/-} 0.196, p<0.0001) and POCUS (DSC 0.857 {+/-} 0.047 vs. 0.667 {+/-} 0.279, p<0.0001). Additionally, SAM-enhanced workflow reduced annotation time by 50% (11.6 {+/-} 4.5 sec vs. 5.7 {+/-} 1.7 sec, p<0.0001) while maintaining segmentation quality. We demonstrated an effective strategy for fine-tuning a vision foundation model for enhancing clinical workflow efficiency and supporting human-AI collaboration.

BackgroundAccurate left ventricular outflow tract obstruction (LVOTO) assessment is crucial for hypertrophic cardiomyopathy (HCM) management and prognosis. Traditional methods, requiring multiple views, Doppler, and provocation, is often infeasible, especially where resources are limited. This study aimed to develop and validate a deep learning (DL) model capable of predicting severe LVOTO in HCM patients using only the parasternal long-axis (PLAX) view from transthoracic echocardiography (TTE). MethodsA DL model was trained on PLAX videos extracted from TTE examinations (developmental dataset, n=1,007) to capture both morphological and dynamic motion features, generating a DL index for LVOTO (DLi-LVOTO, range 0-100). Performance was evaluated in an internal test dataset (ITDS, n=87) and externally validated in the distinct hospital dataset (DHDS, n=1,334) and the LVOTO reduction treatment dataset (n=156). ResultsThe model achieved high accuracy in detecting severe LVOTO (pressure gradient[&ge;] 50mmHg), with area under the receiver operating characteristics curve (AUROC) of 0.97 (95% confidence interval: 0.92-1.00) in ITDS and 0.93 (0.92-0.95) in DHDS. At a DLi-LVOTO threshold of 70, the model demonstrated a specificity of 97.3% and negative predictive value (NPV) of 96.1% in ITDS. In DHDS, a cutoff of 60 yielded a specificity of 94.6% and NPV of 95.5%. DLi-LVOTO also decreased significantly after surgical myectomy or Mavacamten treatment, correlating with reductions in peak pressure gradient (p<0.001 for all). ConclusionsOur DL-based approach predicts severe LVOTO using only the PLAX view from TTE, serving as a complementary tool, particularly in resource-limited settings or when Doppler is unavailable, and for monitoring treatment response.

BackgroundLung ultrasound (LUS) offers advantages over traditional imaging for diagnosing pulmonary conditions, with superior accuracy compared to chest X-ray and similar performance to CT at lower cost. Despite these benefits, widespread adoption is limited by operator dependency, moderate interrater reliability, and training requirements. Deep learning (DL) could potentially address these challenges, but development of effective algorithms is hindered by the scarcity of comprehensive image repositories with proper metadata. MethodsWe created an open-source dataset of LUS images derived a multi-center study involving N=226 adult patients presenting with respiratory symptoms to emergency departments between March 2020 and April 2022. Images were acquired using a standardized scanning protocol (12-zone or modified 8-zone) with various point-of-care ultrasound devices. Three blinded researchers independently analyzed each image following consensus guidelines, with disagreements adjudicated to provide definitive interpretations. Videos were pre-processed to remove identifiers, and frames were extracted and resized to 128x128 pixels. ResultsThe dataset contains 1,874 video clips comprising 303,977 frames. Half of the participants (50%) had COVID-19 pneumonia. Among all clips, 66% contained no abnormalities, 18% contained B-lines, 4.5% contained consolidations, 6.4% contained both B-lines and consolidations, and 5.2% had indeterminate findings. Pathological findings varied significantly by lung zone, with anterior zones more frequently normal and less likely to show consolidations compared to lateral and posterior zones. DiscussionThis dataset represents one of the largest annotated LUS repositories to date, including both COVID-19 and non-COVID-19 patients. The comprehensive metadata and expert interpretations enhance its utility for DL applications. Despite limitations including potential device-specific characteristics and COVID-19 predominance, this repository provides a valuable resource for developing AI tools to improve LUS acquisition and interpretation.